Roomaney A, Womersley J, Swart P, Spies G, Seedat S, Hemmings S
IBRO Neurosci Rep. 2022; 12:45-54.
PMID: 35746967
PMC: 9210473.
DOI: 10.1016/j.ibneur.2021.12.003.
Pascale E, Cimino S, Cerniglia L, Bevilacqua A
Eat Weight Disord. 2022; 27(7):2605-2616.
PMID: 35508584
PMC: 9556347.
DOI: 10.1007/s40519-022-01408-4.
Bonvicini C, Cortese S, Maj C, Baune B, Faraone S, Scassellati C
Transl Psychiatry. 2020; 10(1):70.
PMID: 32075956
PMC: 7031506.
DOI: 10.1038/s41398-020-0755-4.
Akutagava-Martins G, Salatino-Oliveira A, Kieling C, Genro J, Polanczyk G, Anselmi L
J Psychiatry Neurosci. 2016; 41(6):405-412.
PMID: 27327562
PMC: 5082511.
DOI: 10.1503/jpn.150270.
Zhang S, Jiang W, Tang X, Xu Q, Wang J, Gui R
Int J Clin Exp Med. 2015; 8(3):4606-10.
PMID: 26064393
PMC: 4443227.
Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
de Azeredo L, Rovaris D, Mota N, Polina E, Marques F, Contini V
Eur Arch Psychiatry Clin Neurosci. 2014; 264(5):401-8.
PMID: 24487615
DOI: 10.1007/s00406-014-0486-8.
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
Mergy M, Gowrishankar R, Davis G, Jessen T, Wright J, Stanwood G
Neurochem Int. 2013; 73:56-70.
PMID: 24332984
PMC: 4177817.
DOI: 10.1016/j.neuint.2013.11.009.
Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals.
Horn A, Scheller C, Du Plessis S, Arendt G, Nolting T, Joska J
J Neural Transm (Vienna). 2013; 120(10):1411-9.
PMID: 24057505
PMC: 3779317.
DOI: 10.1007/s00702-013-1086-x.
The Brazilian contribution to Attention-Deficit/Hyperactivity Disorder molecular genetics in children and adolescents.
Genro J, Roman T, Rohde L, Hutz M
Genet Mol Biol. 2013; 35(4 (suppl)):932-8.
PMID: 23411749
PMC: 3571428.
DOI: 10.1590/s1415-47572012000600007.
DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.
Turic D, Swanson J, Sonuga-Barke E
Pharmgenomics Pers Med. 2012; 3:61-78.
PMID: 23226043
PMC: 3513209.
DOI: 10.2147/pgpm.s6800.
Gene-environment interaction in externalizing problems among adolescents: evidence from the Pelotas 1993 Birth Cohort Study.
Kieling C, Hutz M, Genro J, Polanczyk G, Anselmi L, Camey S
J Child Psychol Psychiatry. 2012; 54(3):298-304.
PMID: 23215821
PMC: 3736152.
DOI: 10.1111/jcpp.12022.
Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorder.
Gonon F, Konsman J, Cohen D, Boraud T
PLoS One. 2012; 7(9):e44275.
PMID: 22984483
PMC: 3440402.
DOI: 10.1371/journal.pone.0044275.
Role of dopamine receptors in ADHD: a systematic meta-analysis.
Wu J, Xiao H, Sun H, Zou L, Zhu L
Mol Neurobiol. 2012; 45(3):605-20.
PMID: 22610946
DOI: 10.1007/s12035-012-8278-5.
Cathechol-O-methyltransferase Val(158)Met polymorphism is associated with disruptive behavior disorders among children and adolescents with ADHD.
Salatino-Oliveira A, Genro J, Guimaraes A, Chazan R, Zeni C, Schmitz M
J Neural Transm (Vienna). 2012; 119(6):729-33.
PMID: 22270685
DOI: 10.1007/s00702-012-0766-2.
Genetic factors modulating the response to stimulant drugs in humans.
Hart A, de Wit H, Palmer A
Curr Top Behav Neurosci. 2012; 12:537-77.
PMID: 22261702
PMC: 3388157.
DOI: 10.1007/7854_2011_187.
Adolescent rat circadian activity is modulated by psychostimulants.
Bergheim M, Yang P, Burau K, Dafny N
Brain Res. 2011; 1431:35-45.
PMID: 22146676
PMC: 3271788.
DOI: 10.1016/j.brainres.2011.10.027.
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood.
Nemoda Z, Szekely A, Sasvari-Szekely M
Neurosci Biobehav Rev. 2011; 35(8):1665-86.
PMID: 21527290
PMC: 3133854.
DOI: 10.1016/j.neubiorev.2011.04.002.
Epistasis between neurochemical gene polymorphisms and risk for ADHD.
Segurado R, Bellgrove M, Manconi F, Gill M, Hawi Z
Eur J Hum Genet. 2011; 19(5):577-82.
PMID: 21368917
PMC: 3083627.
DOI: 10.1038/ejhg.2010.250.
ADHD and the DRD4 exon III 7-repeat polymorphism: an international meta-analysis.
Nikolaidis A, Gray J
Soc Cogn Affect Neurosci. 2009; 5(2-3):188-93.
PMID: 20019071
PMC: 2894686.
DOI: 10.1093/scan/nsp049.
Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.
Wanchoo S, Lee M, Swann A, Dafny N
Brain Res. 2009; 1312:89-100.
PMID: 19932692
PMC: 4036823.
DOI: 10.1016/j.brainres.2009.11.035.